ACE-031 IGF-1 LR3 Vial Stack
ACE-031 IGF-1 LR3 Vial Stack is supplied as two individual vials (1mg ACE-031 and 0.1mg IGF-1 LR3). The laboratory research material is for scientific, analytical, and educational research purposes.
NEW
97.3% purityBatch COA includedStore 2–8°C
$145.39
Buy more, save more
7.5% offspend $250.00
12.5% offspend $400.00
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
481 in stock
Researchers who bought ACE-031 IGF-1 LR3 Vial Stack also bought
ACE-031 IGF-1 LR3 Vial Stack
ACE-031 IGF-1 LR3 Vial Stack is a laboratory research material supplied by Direct SARMs India for scientific and analytical investigation. ACE-031 is a soluble activin receptor type IIB (ActRIIB) ligand-trap protein, while IGF-1 LR3 is a modified analog of insulin-like growth factor-1. Both compounds have been examined in published research involving receptor signaling, growth-factor biology, and related molecular processes. The stack is provided as lyophilized powder in a sterile glass vial for laboratory research. Researchers may review the COA and HPLC purity report, where available, before using this material in their research.
Benefits of the vial format
1
Accurate dosage. Peptides supplied in vials allow precise, consistent dosing for error-free research outcomes.
2
Convenience. Vials are small and easy to store and transport, helping maintain purity and efficacy.
3
Sterile packaging. Glass vials are sterile, reducing contamination risk and protecting sample integrity.
4
Maintains shelf life. Sealed vials prolong the usable life of the peptide and maintain its effectiveness.
5
Simple dispensing. A user-friendly format makes it simple to draw the intended research volume.
Visit the ACE-031 Research Hub ▸
Visit the IGF-1 LR3 Research Hub ▸
ACE-031 IGF-1 LR3 is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy ACE-031 IGF-1 LR3 Vial Stack India from Direct SARMS.
Additional information
| Size(s) | 1mg |
| Purity | 97.3% |
| Molecular Formula | C400H625N111O115S9 |
| Molecular Weight | |
| Sequence | MFPAMP LSSLFV NGPRTL CGAELV DALQFV CGDRGF YFNKPT GYGSSS RRAPQT GIVDEC CFRSCD LRRLEM YCAPLK PAKSA |
| Physical Form | White or almost white lyophilized powder |
| Size | 0.1 mg |
| Purity | 97.3% |
| Molecular Formula | C400H625N111O115S9 |
| Molecular Weight | 9111 Da |
| Sequence | MFPAMP LSSLFV NGPRTL CGAELV DALQFV CGDRGF YFNKPT GYGSSS RRAPQT GIVDEC CFRSCD LRRLEM YCAPLK PAKSA |
| Physical Form | White or almost white powder |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the sealed lyophilised vial as stated on the product label. Once reconstituted, refrigerate and keep away from light. Do not refreeze a reconstituted solution.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this ACE-031 IGF-1 LR3 compound?
The ACE-031 & IGF-1 LR3 Vial Stack contains separate vials of ACE-031 and IGF-1 LR3 supplied together as a laboratory research stack. ACE-031 is a soluble activin type IIB receptor-based protein, while IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 with reduced affinity for IGF-binding proteins.
The compounds are supplied in separate vials so that each research material remains individually identifiable and can be documented and evaluated independently within a laboratory setting. This is particularly relevant because ACE-031 and IGF-1 LR3 are structurally distinct research materials associated with different signalling systems.
On the contrary, the stack comprises separate vials of ACE-031 and IGF-1 LR3 rather than a single pre-mixed formulation. By keeping the different materials separate, researchers are able to clearly identify each compound and refer to the analytical documentation associated with each vial.
The two materials have been investigated in different areas of muscle-related signalling research. ACE-031 has been studied through modulation of ActRIIB ligand signalling, including myostatin and activin pathways, while IGF-1 LR3 has been used experimentally to investigate IGF-associated signalling and the influence of reduced IGF-binding protein affinity. Their inclusion within the same research programme does not establish that the combination has a clinically validated effect.
Available analytical documentation should be reviewed separately for the ACE-031 and IGF-1 LR3 components of the stack. Certificates of Analysis and associated laboratory reports can provide batch-specific information relevant to material identification, reported purity and quality assessment. These documents relate to the supplied research materials and should not be interpreted as evidence of clinical efficacy or suitability for human use.
Certificate of Analysis
| Identity | ACE-031 IGF-1 LR3 | CONFORMS |
| Purity (HPLC) | 97.3% | CONFORMS |
| Mass (LC-MS) | 9111 Da | CONFORMS |
| Appearance | White or almost white powder | CONFORMS |
